• info@afast.net
  • 678-831-0014

Moving toward a pay-for-value model of prescription drug pricing

  • -

Moving toward a pay-for-value model of prescription drug pricing

Tags : 


Moving toward a pay-for-value model of prescription drug pricing
Drug manufacturers, however, argue that Medicaid’s “best-price rule” inhibits their ability to enter into these new pricing arrangements. Not so fast …
Source: Medicaid
Moving toward a pay-for-value model of prescription drug pricing
Medicaid
Drug manufacturers, however, argue that Medicaid’s “best-price rule” inhibits their ability to enter into these new pricing arrangements. Not so fast …


AFAST cannot survive without your support. We are always in need of volunteers, old smartphones and tablets and of course money.